ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention [Anatol J Cardiol]
Anatol J Cardiol. 2017; 18(5): 376-377 | DOI: 10.14744/AnatolJCardiol.2017.8009

Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention

Michael Spartalis1, Eleni Tzatzaki1, Nikolaos I. Nikiteas2, Eleftherios Spartalis2
1Division of Cardiology, Onassis Cardiac Surgery Center, Athens-Greece
2Laboratory of Experimental Surgery and Surgical Research, University of Athens Medical School, Athens-Greece


Michael Spartalis, Eleni Tzatzaki, Nikolaos I. Nikiteas, Eleftherios Spartalis. Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention. Anatol J Cardiol. 2017; 18(5): 376-377

Corresponding Author: Michael Spartalis, Greece
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.